Hsing Jung Yeh

Dr. Hsing Jung Yeh

Taipei Medical University Hospital, Taipei, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
CLChung-Ming Lo
Chung-Ming Lo
YYYu-Hsuan Yeh
Yu-Hsuan Yeh
JTJui-Hsiang Tang
Jui-Hsiang Tang
CCChun-Chao Chang
Chun-Chao Chang
HYHsing Jung Yeh
Hsing Jung Yeh
Colorectal cancer is the leading cause of cancer-associated morbidity and mortality worldwide. One of the causes of developing colorectal cancer is untreated colon adenomatous polyps. Clinically, polyps are detected in colonoscopy and the malignancies are determined according to the biopsy. To provide a quick and objective assessment to gastroenterologists, this study proposed a quantitative polyp classification via various image features in colonoscopy. The collected image database was composed of 1991 images including 1053 hyperplastic polyps and 938 adenomatous polyps and adenocarcinomas. From each image, textural features were extracted and combined in machine learning classifiers and machine-generated features were automatically selected in deep convolutional neural networks (DCNN). The DCNNs included AlexNet, Inception-V3, ResNet-101, and DenseNet-201. AlexNet trained from scratch achieved the best performance of 96.4% accuracy which is better than transfer learning and textural features. Using the prediction models, the malignancy level of polyps can be evaluated during a colonoscopy to provide a rapid treatment plan.

Verified
Journal Article
Open access
PDF file
CCChun-Chao Chang
Chun-Chao Chang
CLChih-Yi Liu
Chih-Yi Liu
ISI-Chia Su
I-Chia Su
YLYuarn-Jang Lee
Yuarn-Jang Lee
HYHsing Jung Yeh
Hsing Jung Yeh
CHChi-Jung Huang
Chi-Jung Huang
Inflammatory bowel disease (IBD) is associated with dysbiosis and intestinal barrier dysfunction, as indicated by epithelial hyperpermeability and high levels of mucosal-associated bacteria. Changes in gut microbiota may be correlated with IBD pathogenesis. Additionally, microbe-based treatments could mitigate clinical IBD symptoms. Plasmon-activated water (PAW) is known to have an anti-inflammatory potential. In this work, we studied the association between the anti-inflammatory ability of PAW and intestinal microbes, thereby improving IBD treatment. We examined the PAW-induced changes in the colonic immune activity and microbiota of mice by immunohistochemistry and next generation sequencing, determined whether drinking PAW can mitigate IBD induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS) and dysbiosis through mice animal models. The effects of specific probiotic species on mice with TNBS-induced IBD were also investigated. Experimental results indicated that PAW could change the local inflammation in the intestinal microenvironment. Moreover, the abundance of Akkermansia spp. was degraded in the TNBS-treated mice but elevated in the PAW-drinking mice. Daily rectal injection of Akkermansia muciniphila, a potential probiotic species in Akkermansia spp., also improved the health of the mice. Correspondingly, both PAW consumption and increasing the intestinal abundance of Akkermansia muciniphila can mitigate IBD in mice. These findings indicate that increasing the abundance of Akkermansia muciniphila in the gut through PAW consumption or other methods may mitigate IBD in mice with clinically significant IBD.

20 August 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
PLPei Lin
Pei Lin
CCChun-Chao Chang
Chun-Chao Chang
KYKUO-CHING YUAN
KUO-CHING YUAN
HYHsing Jung Yeh
Hsing Jung Yeh
SFSheng-Uei Fang
Sheng-Uei Fang
JCJung-Su Chang
Jung-Su Chang
Red blood cell (RBC) aggregation and iron status are interrelated and strongly influenced by dietary factors, and their alterations pose a great risk of dyslipidemia and metabolic syndrome (MetS). Currently, RBC aggregation-related dietary patterns remain unclear. This study investigated the dietary patterns that were associated with RBC aggregation and their predictive effects on hyperlipidemia and MetS. Anthropometric and blood biochemical data and food frequency questionnaires were collected from 212 adults. Dietary patterns were derived using reduced rank regression from 32 food groups. Adjusted linear regression showed that hepcidin, soluble CD163, and serum transferrin saturation (%TS) independently predicted RBC aggregation (all p < 0.01). Age-, sex-, and log-transformed body mass index (BMI)-adjusted prevalence rate ratio (PRR) showed a significant positive correlation between RBC aggregation and hyperlipidemia (p-trend < 0.05). RBC aggregation and iron-related dietary pattern scores (high consumption of noodles and deep-fried foods and low intake of steamed, boiled, and raw food, dairy products, orange, red, and purple vegetables, white and light-green vegetables, seafood, and rice) were also significantly associated with hyperlipidemia (p-trend < 0.05) and MetS (p-trend = 0.01) after adjusting for age, sex, and log-transformed BMI. Our results may help dieticians develop dietary strategies for preventing dyslipidemia and MetS.

5 January 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
CLChung-Ming Lo
Chung-Ming Lo
SCSean Chun-Chang Chen
Sean Chun-Chang Chen
YYYu-Hsuan Yeh
Yu-Hsuan Yeh
CCChun-Chao Chang
Chun-Chao Chang
HYHsing Jung Yeh
Hsing Jung Yeh
Melanosis coli (MC) is a disease related to long-term use of anthranoid laxative agents. Patients with clinical constipation or obesity are more likely to use these drugs for long periods. Moreover, patients with MC are more likely to develop polyps, particularly adenomatous polyps. Adenomatous polyps can transform to colorectal cancer. Recognizing multiple polyps from MC is challenging due to their heterogeneity. Therefore, this study proposed a quantitative assessment of MC colonic mucosa with texture patterns. In total, the MC colonoscopy images of 1092 person-times were included in this study. At the beginning, the correlations among carcinoembryonic antigens, polyp texture, and pathology were analyzed. Then, 181 patients with MC were extracted for further analysis while patients having unclear images were excluded. By gray-level co-occurrence matrix, texture patterns in the colorectal images were extracted. Pearson correlation analysis indicated five texture features were significantly correlated with pathological results (p < 0.001). This result should be used in the future to design an instant help software to help the physician. The information of colonoscopy and image analystic data can provide clinicians with suggestions for assessing patients with MC.

20 January 2026 in Cureus
Verified
Journal Article
Open access
PDF file
SSShao Chi Lo Sr.
Shao Chi Lo Sr.
HSHsing Jung Yeh Sr.
Hsing Jung Yeh Sr.
HYHsing Jung Yeh
Hsing Jung Yeh
Semaglutide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA), has shown robust efficacy in glycemic control, weight reduction, and cardiovascular protection, but concerns remain regarding rare adverse events such as acute pancreatitis. We report a 59-year-old man with type 2 diabetes, stage IIIA colon cancer post-hemicolectomy and chemotherapy, stage 4 chronic kidney disease, hypertension, and dyslipidemia who developed acute pancreatitis after 2.5 years of weekly semaglutide therapy. He presented with epigastric pain and elevated lipase, while abdominal ultrasound revealed only mild pancreatic parenchymal heterogeneity without peripancreatic fluid collection. The patient improved with conservative management, and semaglutide was discontinued in favor of linagliptin, with no recurrence of symptoms during three months of follow-up. This case highlights the potential risk of pancreatitis in patients with multimorbidity, a population frequently excluded from randomized controlled trials and underrepresented in real-world prescribing due to socioeconomic barriers. Clinicians should remain vigilant when prescribing semaglutide to patients with multiple underlying chronic conditions, and further studies focusing on multimorbid populations are warranted to clarify its safety profile.

18 March 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
HYHsing Jung Yeh
Hsing Jung Yeh
HCHung-Ming Chao
Hung-Ming Chao
CCChun-Chao Chang
Chun-Chao Chang
WKWei-Yu Kao
Wei-Yu Kao
SYSuh Ching Yang
Suh Ching Yang
Chun-Kuang ShihChun-Kuang Shih
Chun-Kuang Shih
Background: Chenopodium formosanum Koidz. (djulis) is an indigenous cereal crop native to Taiwan, and its effects on patients with inflammatory bowel disease (IBD) warrant exploration. The present study investigated whether the consumption of djulis can alleviate chronic colitis induced by dextran sulfate sodium (DSS) in mice. Methods: Forty mice were randomly divided into five groups: blank group (B), control group (C), low-dose group (L), medium-dose group (M), and high-dose group (H). Body weight and disease activity index (DAI) were recorded throughout this study. Groups C, L, M, and H were administered 2% DSS water on days 1–5 and 10–15 to induce chronic colitis. Groups L, M, and H were administered 5%, 10%, and 15% djulis, respectively. Serum and colon samples were collected for further analysis. Results: The DAI scores of groups L, M, and H were significantly lower than those of group C (p < 0.05), and the DAI scores of group H on day 18 were significantly lower than those of group L (p < 0.05). Colon length analysis revealed that DSS intervention significantly shortened colon length in group C (p < 0.05), whereas mice consuming djulis (groups L, M, and H) exhibited a restoration of colon length, with the effect being most pronounced in group H. DSS significantly increased the secretion of certain pro-inflammatory cytokines in the serum, such as interleukin (IL)-1β (p < 0.05), and the expression of some pro-inflammatory proteins in the colon, such as the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (p < 0.05); however, djulis reversed these effects (especially in group H). In addition, mice in group H exhibited beneficial gut microbiota. Conclusions: Djulis alleviated chronic colitis in mice by reducing inflammation and modulating the gut microbiota. Further research is required to confirm these potential benefits in humans and elucidate the mechanisms involved.